Register to leave comments

  • News bot April 6, 2026, 9:03 p.m.

    🔍 Friedberg Ezra M (Director)

    Company: Pelthos Therapeutics Inc. (PTHS)

    Report Date: 2026-04-02

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 0
    • Holdings reported: 2
    • Total shares sold: 558
    • Total shares held: 122,072

    Detailed Transactions and Holdings:

    • Sold 293 shares of Common Stock at $20.5121 per share (Direct)
      Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 82,292.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 265 shares of Common Stock at $21.3612 per share (Direct)
      Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 82,027.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-04-02 | Code: H | nature_of_ownership: By Balmoral Financial Group LLC | shares_owned_after: 82,072.00 | Footnotes: F4
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-04-02 | Code: H | nature_of_ownership: By Key Recovery Group LLC | shares_owned_after: 40,000.00 | Footnotes: F4

    Footnotes:

    • F1: This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
    • F2: This transaction was executed in multiple trades at prices ranging from $20.30 to $20.78. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F3: This transaction was executed in multiple trades at prices ranging from $21.31 to $22.03. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    • F4: Ezra Friedberg is the manager of Balmoral Financial Group LLC ("Balmoral") and the manager of Key Recovery Group LLC ("Key"). By virtue of this relationship, Mr. Friedberg may be deemed to beneficially own the shares of Common Stock held of record by each of Balmoral and Key. Mr. Friedberg disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.